Samsung BioLogics, a contract biologics manufacturer, and Merck Millipore have signed a memorandum of understanding for a strategic alliance to encompass a long-term supply agreement in which Merck Millipore will provide raw materials  to Samsung BioLogics for biopharmaceutical manufacturing.

Merck Millipore will become an essential raw material supplier for Samsung BioLogics' 30,000-liter facility as well as its new 150,000-liter  facility that is expected to be completed in 2015 in Songdo, Incheon, South Korea.

Source: Samsung Biologics